<table border="0" cellpadding="0" cellspacing="0" width="border-collapse: collapse" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Drugs that Affect Renal Function<br/>
</td>
<td colspan="2" stylecode="Rrule" valign="top">A decline in GFR or tubular secretion, as from ACE inhibitors, angiotensin receptor blockers, nonsteroidal anti-inflammatory drugs [NSAIDS], COX-2 inhibitors may impair the excretion of digoxin.<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Antiarrthymics<br/>
</td>
<td stylecode="Rrule" valign="top">Dofetilide<br/>
</td>
<td stylecode="Rrule" valign="top">Concomitant administration with digoxin was associated with  a higher rate of torsades de pointes<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <br/>
</td>
<td stylecode="Rrule" valign="top">Sotalol<br/>
</td>
<td stylecode="Rrule" valign="top">Proarrthythmic events were more common in patients receiving sotalol and digoxin than on either alone; it is not clear whether this represents an interaction or is related to the presence of CHF, a known risk factor for proarrhythmia, in patients receiving digoxin<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <br/>
</td>
<td stylecode="Rrule" valign="top">Dronedarone<br/>
</td>
<td stylecode="Rrule" valign="top">Sudden death was more common in patients receiving digoxin with dronedarone than on either alone; it is not clear whether this represents an interaction or is related to the presence of advanced heart disease, a known risk factor for sudden death in patients receiving digoxin<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Parathyroid Hormone Analog<br/>
</td>
<td stylecode="Rrule" valign="top">Teriparatide<br/>
</td>
<td stylecode="Rrule" valign="top">Sporadic case reports have suggested that hypercalcemia may predispose patients to digitalis toxicity. Teriparatide transiently increases serum calcium.<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Thyroid supplement<br/>
</td>
<td stylecode="Rrule" valign="top">Thyroid Supplement<br/>
</td>
<td stylecode="Rrule" valign="top">Treatement of hypothyroidism in patients taking digoxin may increase the dose requirements of digoxin.<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Sympathomimetics<br/>
</td>
<td stylecode="Rrule" valign="top">Epineprine <br/>Noreprinephrine<br/>Dopamine<br/>
</td>
<td stylecode="Rrule" valign="top">Can increase the risk of cardiac arrhythmias<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Neuromuscular Blocking Agents<br/>
</td>
<td stylecode="Rrule" valign="top">Succinylcholine <br/> <br/>
</td>
<td stylecode="Rrule" valign="top">May cause sudden extrusion of<br/>potassium frommuscle cells causing arrhythmias inpatients<br/>taking digoxin<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Supplements<br/>
</td>
<td stylecode="Rrule" valign="top">Calcium<br/>
</td>
<td stylecode="Rrule" valign="top">If administered rapidly by intravenous route, can<br/>produce serious arrhythmias in digitalized<br/>patients.<br/>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule" valign="top">Beta-adrenergic blockers and calcium channel blockers<br/>
</td>
<td stylecode="Rrule" valign="top"> <br/>
</td>
<td stylecode="Rrule" valign="top">Additive effects on AV node conduction can result in bradycardia and advanced or complete<br/>heart block.<br/>
</td>
</tr>
</tbody>
</table>